Clinical Trials Logo

Solid Tumor, AML Adult clinical trials

View clinical trials related to Solid Tumor, AML Adult.

Filter by:
  • None
  • Page 1

NCT ID: NCT04372706 Terminated - Clinical trials for Solid Tumor, AML Adult

RTX-240 Monotherapy and in Combination With Pembrolizumab

Start date: May 6, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Open label, multicenter, multidose, first-in-human Phase 1/2 study of RTX-240 monotherapy or in combination of pembrolizumab for the treatment of patients with (1) relapsed/refractory R/R or locally advanced solid tumors (Phase 1/2) or (2) R/R Acute Myeloid Leukemia (AML) (Phase 1 only).